174 related articles for article (PubMed ID: 29707916)
1. Association between Parathyroid Hormone and Cardiovascular Disease.
Fujii H
Ther Apher Dial; 2018 Jun; 22(3):236-241. PubMed ID: 29707916
[TBL] [Abstract][Full Text] [Related]
2. Serum levels of phosphorus, parathyroid hormone, and calcium and risks of death and cardiovascular disease in individuals with chronic kidney disease: a systematic review and meta-analysis.
Palmer SC; Hayen A; Macaskill P; Pellegrini F; Craig JC; Elder GJ; Strippoli GF
JAMA; 2011 Mar; 305(11):1119-27. PubMed ID: 21406649
[TBL] [Abstract][Full Text] [Related]
3. CKD-mineral and bone disorder and risk of death and cardiovascular hospitalization in patients on hemodialysis.
Block GA; Kilpatrick RD; Lowe KA; Wang W; Danese MD
Clin J Am Soc Nephrol; 2013 Dec; 8(12):2132-40. PubMed ID: 24052218
[TBL] [Abstract][Full Text] [Related]
4. [Strategies aiming to control hyperphosphatemia in chronic kidney disease].
Ureña Torres PA
Nephrol Ther; 2017 Apr; 13 Suppl 1():S95-S101. PubMed ID: 28577750
[TBL] [Abstract][Full Text] [Related]
5. The Pattern of Serum Calcium, Phosphate and Parathyroid Hormone Levels in Pre-Diagnosed Chronic Kidney Disease Patients.
Rouf MA; Sharif JU; Khan M; Karim MR; Rahman MM; Ahmed H; Parveen R; Islam MS; Farzana MN; Rahman MA
Mymensingh Med J; 2018 Jan; 27(1):18-25. PubMed ID: 29459587
[TBL] [Abstract][Full Text] [Related]
6. Aldosterone and parathyroid hormone interactions as mediators of metabolic and cardiovascular disease.
Tomaschitz A; Ritz E; Pieske B; Rus-Machan J; Kienreich K; Verheyen N; Gaksch M; Grübler M; Fahrleitner-Pammer A; Mrak P; Toplak H; Kraigher-Krainer E; März W; Pilz S
Metabolism; 2014 Jan; 63(1):20-31. PubMed ID: 24095631
[TBL] [Abstract][Full Text] [Related]
7. How abnormal calcium, phosphate, and parathyroid hormone relate to cardiovascular disease.
Bro S
Nephrol Nurs J; 2003 Jun; 30(3):275-81; quiz 282-3. PubMed ID: 12861895
[TBL] [Abstract][Full Text] [Related]
8. Relation between Calcium, Phosphorus, Calcium-Phosphorus Index and iPTH in Chronic Kidney Disease Patients.
Adhikary LP; Yadava SK; Pokharel A; Khadka D; Thakur R
J Nepal Health Res Counc; 2015; 13(29):50-3. PubMed ID: 26411713
[TBL] [Abstract][Full Text] [Related]
9. Aldosterone and parathyroid hormone: a complex and clinically relevant relationship.
Pilz S; Tomaschitz A; März W; Cavalier E; Ritz E
Calcif Tissue Int; 2010 Oct; 87(4):373-4. PubMed ID: 20721661
[No Abstract] [Full Text] [Related]
10. The Interplay Between the Renin-Angiotensin-Aldosterone System and Parathyroid Hormone.
Zheng MH; Li FX; Xu F; Lin X; Wang Y; Xu QS; Guo B; Yuan LQ
Front Endocrinol (Lausanne); 2020; 11():539. PubMed ID: 32973674
[TBL] [Abstract][Full Text] [Related]
11. Phosphate enters the syzygy.
Yee J
Adv Chronic Kidney Dis; 2011 Mar; 18(2):55-6. PubMed ID: 21406287
[No Abstract] [Full Text] [Related]
12. The renin-angiotensin-aldosterone system and calcium-regulatory hormones.
Vaidya A; Brown JM; Williams JS
J Hum Hypertens; 2015 Sep; 29(9):515-21. PubMed ID: 25631218
[TBL] [Abstract][Full Text] [Related]
13. Cardiovascular pathophysiology in chronic kidney disease: opportunities to transition from disease to health.
Tomey MI; Winston JA
Ann Glob Health; 2014; 80(1):69-76. PubMed ID: 24751567
[TBL] [Abstract][Full Text] [Related]
14. Low parathyroid hormone status induced by high dialysate calcium is an independent risk factor for cardiovascular death in hemodialysis patients.
Merle E; Roth H; London GM; Jean G; Hannedouche T; Bouchet JL; Drüeke T; Fouque D; Daugas E;
Kidney Int; 2016 Mar; 89(3):666-74. PubMed ID: 26880460
[TBL] [Abstract][Full Text] [Related]
15. [CKD-MBD and cardiovascular disease.].
Fujii H
Clin Calcium; 2019; 29(2):179-184. PubMed ID: 30679398
[TBL] [Abstract][Full Text] [Related]
16. Restoration of parathyroid function after change of phosphate binder from calcium carbonate to lanthanum carbonate in hemodialysis patients with suppressed serum parathyroid hormone.
Inaba M; Okuno S; Nagayama H; Yamada S; Ishimura E; Imanishi Y; Shoji S
J Ren Nutr; 2015 Mar; 25(2):242-6. PubMed ID: 25556148
[TBL] [Abstract][Full Text] [Related]
17. Furosemide stimulation of parathormone in humans: role of the calcium-sensing receptor and the renin-angiotensin system.
Muller ME; Forni Ogna V; Maillard M; Stoudmann C; Zweiacker C; Anex C; Wuerzner G; Burnier M; Bonny O
Pflugers Arch; 2015 Dec; 467(12):2413-21. PubMed ID: 26089029
[TBL] [Abstract][Full Text] [Related]
18. Does it matter how parathyroid hormone levels are suppressed in secondary hyperparathyroidism?
Stubbs JR; Wetmore JB
Semin Dial; 2011; 24(3):298-306. PubMed ID: 21682772
[TBL] [Abstract][Full Text] [Related]
19. Effect Modifying Role of Serum Calcium on Mortality-Predictability of PTH and Alkaline Phosphatase in Hemodialysis Patients: An Investigation Using Data from the Taiwan Renal Registry Data System from 2005 to 2012.
Lin YC; Lin YC; Hsu CY; Kao CC; Chang FC; Chen TW; Chen HH; Hsu CC; Wu MS;
PLoS One; 2015; 10(6):e0129737. PubMed ID: 26107510
[TBL] [Abstract][Full Text] [Related]
20. Aldosterone antagonist therapy and its relationship with inflammation, fibrosis, thrombosis, mineral-bone disorder and cardiovascular complications in peritoneal dialysis (PD) patients.
Donderski R; Stróżecki P; Sulikowska B; Grajewska M; Miśkowiec I; Stefańska A; Siódmiak J; Odrowąż-Sypniewska G; Manitius J
Int Urol Nephrol; 2017 Oct; 49(10):1867-1873. PubMed ID: 28710615
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
